168 related articles for article (PubMed ID: 20404912)
1. Inhibition of the proprotein convertases represses the invasiveness of human primary melanoma cells with altered p53, CDKN2A and N-Ras genes.
Lalou C; Scamuffa N; Mourah S; Plassa F; Podgorniak MP; Soufir N; Dumaz N; Calvo F; Basset-Seguin N; Khatib AM
PLoS One; 2010 Apr; 5(4):e9992. PubMed ID: 20404912
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of proprotein convertases is associated with loss of growth and tumorigenicity of HT-29 human colon carcinoma cells: importance of insulin-like growth factor-1 (IGF-1) receptor processing in IGF-1-mediated functions.
Khatib AM; Siegfried G; Prat A; Luis J; Chrétien M; Metrakos P; Seidah NG
J Biol Chem; 2001 Aug; 276(33):30686-93. PubMed ID: 11402025
[TBL] [Abstract][Full Text] [Related]
3. Opposing function of the proprotein convertases furin and PACE4 on breast cancer cells' malignant phenotypes: role of tissue inhibitors of metalloproteinase-1.
Lapierre M; Siegfried G; Scamuffa N; Bontemps Y; Calvo F; Seidah NG; Khatib AM
Cancer Res; 2007 Oct; 67(19):9030-4. PubMed ID: 17909005
[TBL] [Abstract][Full Text] [Related]
4. Wild-type p53 gene transfer inhibits invasion and reduces matrix metalloproteinase-2 levels in p53-mutated human melanoma cells.
Toschi E; Rota R; Antonini A; Melillo G; Capogrossi MC
J Invest Dermatol; 2000 Jun; 114(6):1188-94. PubMed ID: 10844565
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of proprotein convertases represses the metastatic potential of human colorectal tumor cells.
Scamuffa N; Siegfried G; Bontemps Y; Ma L; Basak A; Cherel G; Calvo F; Seidah NG; Khatib AM
J Clin Invest; 2008 Jan; 118(1):352-63. PubMed ID: 18064302
[TBL] [Abstract][Full Text] [Related]
6. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
7. Gallic acid inhibits the migration and invasion of A375.S2 human melanoma cells through the inhibition of matrix metalloproteinase-2 and Ras.
Lo C; Lai TY; Yang JS; Yang JH; Ma YS; Weng SW; Lin HY; Chen HY; Lin JG; Chung JG
Melanoma Res; 2011 Aug; 21(4):267-73. PubMed ID: 21734530
[TBL] [Abstract][Full Text] [Related]
8. An inhibitor of stress-activated MAP-kinases reduces invasion and MMP-2 expression of malignant melanoma cells.
Denkert C; Siegert A; Leclere A; Turzynski A; Hauptmann S
Clin Exp Metastasis; 2002; 19(1):79-85. PubMed ID: 11918086
[TBL] [Abstract][Full Text] [Related]
9. Furin-like proprotein convertases are central regulators of the membrane type matrix metalloproteinase-pro-matrix metalloproteinase-2 proteolytic cascade in atherosclerosis.
Stawowy P; Meyborg H; Stibenz D; Borges Pereira Stawowy N; Roser M; Thanabalasingam U; Veinot JP; Chrétien M; Seidah NG; Fleck E; Graf K
Circulation; 2005 May; 111(21):2820-7. PubMed ID: 15911696
[TBL] [Abstract][Full Text] [Related]
10. Involvement of furin-like proprotein convertases in the arterial response to injury.
Sluijter JP; Verloop RE; Pulskens WP; Velema E; Grimbergen JM; Quax PH; Goumans MJ; Pasterkamp G; de Kleijn DP
Cardiovasc Res; 2005 Oct; 68(1):136-43. PubMed ID: 15963479
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
[TBL] [Abstract][Full Text] [Related]
12. Tumoral and macrophage uPAR and MMP-9 contribute to the invasiveness of B16 murine melanoma cells.
Marconi C; Bianchini F; Mannini A; Mugnai G; Ruggieri S; Calorini L
Clin Exp Metastasis; 2008; 25(3):225-31. PubMed ID: 18071911
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of proprotein convertases enhances cell migration and metastases development of human colon carcinoma cells in a rat model.
Nejjari M; Berthet V; Rigot V; Laforest S; Jacquier MF; Seidah NG; Remy L; Bruyneel E; Scoazec JY; Marvaldi J; Luis J
Am J Pathol; 2004 Jun; 164(6):1925-33. PubMed ID: 15161629
[TBL] [Abstract][Full Text] [Related]
14. 'Proteolytic switching': opposite patterns of regulation of gelatinase B and its inhibitor TIMP-1 during human melanoma progression and consequences of gelatinase B overexpression.
MacDougall JR; Bani MR; Lin Y; Muschel RJ; Kerbel RS
Br J Cancer; 1999 May; 80(3-4):504-12. PubMed ID: 10408860
[TBL] [Abstract][Full Text] [Related]
15. Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas.
Airola K; Karonen T; Vaalamo M; Lehti K; Lohi J; Kariniemi AL; Keski-Oja J; Saarialho-Kere UK
Br J Cancer; 1999 May; 80(5-6):733-43. PubMed ID: 10360651
[TBL] [Abstract][Full Text] [Related]
16. De-N-acetyl GM3 promotes melanoma cell migration and invasion through urokinase plasminogen activator receptor signaling-dependent MMP-2 activation.
Liu JW; Sun P; Yan Q; Paller AS; Gerami P; Ho N; Vashi N; Le Poole IC; Wang XQ
Cancer Res; 2009 Nov; 69(22):8662-9. PubMed ID: 19903858
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of mutant ras in human melanoma increases invasiveness, proliferation and anchorage-independent growth in vitro and induces tumour formation and cachexia in vivo.
Fujita M; Norris DA; Yagi H; Walsh P; Morelli JG; Weston WL; Terada N; Bennion SD; Robinson W; Lemon M; Maxwell IH; Yohn JJ
Melanoma Res; 1999 Jun; 9(3):279-91. PubMed ID: 10465584
[TBL] [Abstract][Full Text] [Related]
18. Deacetylated GM3 promotes uPAR-associated membrane molecular complex to activate p38 MAPK in metastatic melanoma.
Yan Q; Bach DQ; Gatla N; Sun P; Liu JW; Lu JY; Paller AS; Wang XQ
Mol Cancer Res; 2013 Jun; 11(6):665-75. PubMed ID: 23525268
[TBL] [Abstract][Full Text] [Related]
19. Tissue inhibitor of matrix metalloproteinase-2 regulates matrix metalloproteinase-2 activation by modulation of membrane-type 1 matrix metalloproteinase activity in high and low invasive melanoma cell lines.
Kurschat P; Zigrino P; Nischt R; Breitkopf K; Steurer P; Klein CE; Krieg T; Mauch C
J Biol Chem; 1999 Jul; 274(30):21056-62. PubMed ID: 10409657
[TBL] [Abstract][Full Text] [Related]
20. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.
Kim TD; Song KS; Li G; Choi H; Park HD; Lim K; Hwang BD; Yoon WH
BMC Cancer; 2006 Aug; 6():211. PubMed ID: 16916471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
